Enzastaurin

[email protected]
Enzastaurin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2005-09-19 00:00:00
Sponsor Denovo Biopharma LLC;6331 Nancy Ridge Drive;San Diego, California, 92121
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM